Fibrinolysis and risk of coronary artery disease
- 31 May 1996
- journal article
- review article
- Published by Elsevier in Fibrinolysis
- Vol. 10 (3) , 127-136
- https://doi.org/10.1016/s0268-9499(96)80023-3
Abstract
No abstract availableThis publication has 156 references indexed in Scilit:
- Impaired fibrinolysis early after percutaneous transluminal coronary angioplasty is associated with restenosisAmerican Heart Journal, 1996
- Plasminogen Activator Expression in Human Atherosclerotic LesionsArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Quantification of Plasminogen Activators and Their Inhibitors in the Aortic Vessel Wall in Relation to the Presence and Severity of Atherosclerotic DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Insulin sensitivity is not an independent determinant of plasma plasminogen activator inhibitor-1 activity.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fibrinolysis.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Enzymatic evidence of impaired reperfusion in diabetic patients after thrombolytic therapy for acute myocardial infarction: a role for plasminogen activator inhibitor?Heart, 1993
- Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulin.Journal of Clinical Investigation, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Substrate-bound fibrinogen, fibrin and other cell attachment-promoting proteins as a scaffold for cultured vascular smooth muscle cellsAtherosclerosis, 1992
- Thrombosis and Acute Coronary-Artery Lesions in Sudden Cardiac Ischemic DeathNew England Journal of Medicine, 1984